The ThinkEquity Conference 2024
Herzliya, Israel and Calgary, Alberta, October 21, 2024 - PRISM MediaWire - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in chronic pain management via Liposomal CBD drug products, today announced that it will b...

21 October 2024

News
PITTSBURGH, Oct. 09, 2024 - PRISM MediaWire - Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious diseases with significant unmet needs, today announced that CEO Jonathan Kaufman,...

9 October 2024

News
New York, October 04, 2024 - PRISM MediaWire - IonQ, (NYSE: IONQ) a leading player in the quantum computing industry, has reached a major milestone on its path to scaling quantum systems by demonstrating remote ion-ion entanglement. Building on the ion-photon entanglemen...

4 October 2024

Pharmaceutical
NEW YORK, September 25, 2024 - PRISM MediaWire - PRISM MarketView presents an exclusive Q&A with Dr. Michael Chancellor, Co-founder and Chief Medical Officer of Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO). In this interview, Dr. Chancellor provides insights into the...

25 September 2024

News
PITTSBURGH, Sept. 24, 2024 - PRISM MediaWire - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious diseases with significant unmet needs, today announced an update on its ongoing m...

24 September 2024

News
Strategic Rebranding Reflects Focus on Neurodegenerative Therapies and Healthy Longevity

17 September 2024

Biotechnology
New York, September 10, 2024 - PRISM MediaWire - Aclarion, Inc. (Nasdaq: ACON), a healthcare technology company focused on leveraging biomarkers and augmented intelligence to identify chronic low back pain, announced the completion of the first exams in its ongoing LIFEH...
News
Early Pilot Study Data from Veteran Volunteers is Compelling

4 September 2024

News
· Affecting about 6 million Americans, OLP is a chronic inflammatory disease affecting the mucous membranes of the mouth

22 August 2024

News
· Patents issued in mainland China protect the Company’s novel secreted Klotho protein and Its gene delivery system

8 August 2024

1
2
3
4
5
6
7
We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
Cookie settings
Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
Necessary cookies
Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
Preferences
Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
Analytical cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage.
Marketing cookies
Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.